175 related articles for article (PubMed ID: 36231768)
21. Comparative efficacy of cimetidine, famotidine, ranitidine, and mylanta in postoperative stress ulcers. Gastric pH control and ulcer prevention in patients undergoing coronary artery bypass graft surgery.
Lamothe PH; Rao E; Serra AJ; Castellano J; Woronick CL; McNicholas KW; Lemole GM
Gastroenterology; 1991 Jun; 100(6):1515-20. PubMed ID: 2019357
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for delayed healing of duodenal ulcers treated with famotidine and ranitidine.
Reynolds JC; Schoen RE; Maislin G; Zangari GG
Am J Gastroenterol; 1994 Apr; 89(4):571-80. PubMed ID: 8147361
[TBL] [Abstract][Full Text] [Related]
23. Drug Utilisation Patterns of Alternatives to Ranitidine-Containing Medicines in Patients Treated with Ranitidine: A Network Analysis of Data from Six European National Databases.
Arinze JT; de Ridder MAJ; Vojinovic D; van Ballegooijen H; Markov E; Duarte-Salles T; Rijnbeek P; Verhamme KMC
Drug Saf; 2023 Dec; 46(12):1353-1362. PubMed ID: 37907775
[TBL] [Abstract][Full Text] [Related]
24. N-Nitrosodimethylamine (NDMA) Formation from Ranitidine Impurities: Possible Root Causes of the Presence of NDMA in Ranitidine Hydrochloride.
Yokoo H; Yamamoto E; Masada S; Uchiyama N; Tsuji G; Hakamatsuka T; Demizu Y; Izutsu KI; Goda Y
Chem Pharm Bull (Tokyo); 2021; 69(9):872-876. PubMed ID: 34470951
[TBL] [Abstract][Full Text] [Related]
25. Reduction of N-nitrosodimethylamine formation from ranitidine by ozonation preceding chloramination: influencing factors and mechanisms.
Zou R; Liao X; Zhao L; Yuan B
Environ Sci Pollut Res Int; 2018 May; 25(14):13489-13498. PubMed ID: 29492817
[TBL] [Abstract][Full Text] [Related]
26. Acid aspiration prophylaxis in morbidly obese patients: famotidine vs. ranitidine.
Vila P; Vallès J; Canet J; Melero A; Vidal F
Anaesthesia; 1991 Nov; 46(11):967-9. PubMed ID: 1750602
[TBL] [Abstract][Full Text] [Related]
27. A single night-time dose of famotidine is equivalent to ranitidine in decreasing 24-hour gastric acidity in asymptomatic duodenal ulcer subjects.
Thomson AB; Pinchbeck BR; Kirdeikis J; Zuk L; Marriage B; Prat A
Aliment Pharmacol Ther; 1989 Apr; 3(2):199-210. PubMed ID: 2491470
[TBL] [Abstract][Full Text] [Related]
28. Effect of Oral Ranitidine on Urinary Excretion of N-Nitrosodimethylamine (NDMA): A Randomized Clinical Trial.
Florian J; Matta MK; DePalma R; Gershuny V; Patel V; Hsiao CH; Zusterzeel R; Rouse R; Prentice K; Nalepinski CG; Kim I; Yi S; Zhao L; Yoon M; Selaya S; Keire D; Korvick J; Strauss DG
JAMA; 2021 Jul; 326(3):240-249. PubMed ID: 34180947
[TBL] [Abstract][Full Text] [Related]
29. Exposure to Ranitidine and Risk of Bladder Cancer: A Nested Case-Control Study.
Cardwell CR; McDowell RD; Hughes CM; Hicks B; Murchie P
Am J Gastroenterol; 2021 Aug; 116(8):1612-1619. PubMed ID: 34028367
[TBL] [Abstract][Full Text] [Related]
30. Famotidine vs ranitidine h.s. in acute duodenal ulcer. A multicentre endoscopic trial.
Bianchi Porro G; Lazzaroni M; Barbara L; Corinaldesi R; Blasi A; Mangiameli A; Capurso L; Koch M; Cheli R; Bovero E
Ital J Gastroenterol; 1991 Feb; 23(2):65-9. PubMed ID: 1747505
[TBL] [Abstract][Full Text] [Related]
31. [Comparison between ranitidine, famotidine, and omeprazole in the treatment of bleeding duodenal ulcer].
Maculotti L; Pradella P
Minerva Chir; 1995 Mar; 50(3):279-81. PubMed ID: 7659265
[TBL] [Abstract][Full Text] [Related]
32. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man.
Grimley CE; West JM; Loft DE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082
[TBL] [Abstract][Full Text] [Related]
33.
Mansouri I; Botton J; Semenzato L; Haddy N; Zureik M
J Am Heart Assoc; 2022 Dec; 11(24):e8067. PubMed ID: 36533625
[TBL] [Abstract][Full Text] [Related]
34. Oral intake of ranitidine increases urinary excretion of N-nitrosodimethylamine.
Zeng T; Mitch WA
Carcinogenesis; 2016 Jun; 37(6):625-634. PubMed ID: 26992900
[TBL] [Abstract][Full Text] [Related]
35. The efficacy and tolerability of famotidine and ranitidine on the healing of active duodenal ulcer and during six-month maintenance treatment, with special reference to NSAID/aspirin-related ulcers.
Bank S; Greenberg RE; Magier D; Lavin PT
Clin Ther; 1991; 13(2):304-18. PubMed ID: 1863945
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Poynard T; Lemaire M; Agostini H
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
[TBL] [Abstract][Full Text] [Related]
37. Gastric and esophageal acidity during continuous treatment with H2-antagonists in uncomplicated esophagitis.
Fiorucci S; Santucci L; Perrone E; Abbritti F; Morelli A
Scand J Gastroenterol; 1989 Aug; 24(6):671-7. PubMed ID: 2573143
[TBL] [Abstract][Full Text] [Related]
38. Comparison of 40 mg famotidine nightly and 150 mg ranitidine b.d.: ulcer healing and symptom relief in benign gastric ulcer.
Cochran KM; Cockel R; Crowe J; Dickinson RJ; Gent AE; Kennedy NP; Royston CM; Cedar E; Mann SG
Aliment Pharmacol Ther; 1989 Oct; 3(5):461-70. PubMed ID: 2518859
[TBL] [Abstract][Full Text] [Related]
39. [Comparative efficacy of famotidine and ranitidine in the treatment of acute-phase duodenal ulcer. A French comparative therapeutic trial].
Delvaux M; Hagège CG; Ribet A
Gastroenterol Clin Biol; 1989 Dec; 13(12):1055-9. PubMed ID: 2696659
[TBL] [Abstract][Full Text] [Related]
40. A multicentre, randomized, double-blind study comparing nocte famotidine or ranitidine for the treatment of active duodenal ulceration.
Alcalá Santaella R; Guardia J; Pajares J; Piqué J; Pita L; Alvárez E; Castellanos P; Guarner L; Ortiz J; Pesquera R
Aliment Pharmacol Ther; 1989 Feb; 3(1):103-10. PubMed ID: 2491454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]